XERO LIMITED (XRO)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

XRO

XRO - XERO LIMITED

FNArena Sector : Accountancy
Year End: March
GICS Industry Group : Software & Services
Debt/EBITDA: 2.64
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS | ALL-TECH

Xero is a New Zealand-founded cloud accounting software company serving small businesses and advisers globally, with major markets including Australia, New Zealand, the UK and the US. Avoid a fixed subscriber count unless maintained.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$79.35

19 Nov
2026

0.010

OPEN

$78.00

0.01%

HIGH

$80.40

1,603,322

LOW

$77.56

TARGET
$115.533 45.6% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
RKN .
FNARENA'S MARKET CONSENSUS FORECASTS
XRO: 1
Title FY27
Forecast
FY28
Forecast
EPS (cps) 113.5 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 66.0 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

$ 

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx90.4
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx2,446.4 M
Book Value Per Share xxxxxxxxxxxxxxx2,638.6
Net Operating Cash Flow xxxxxxxxxxxxxxx829.2 M
Net Profit Margin xxxxxxxxxxxxxxx6.08 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx4.58 %
Return on Invested Capital xxxxxxxxxxxxxxx4.09 %
Return on Assets xxxxxxxxxxxxxxx2.56 %
Return on Equity xxxxxxxxxxxxxxx4.58 %
Return on Total Capital xxxxxxxxxxxxxxx6.87 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx820.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx1,077 M
Long Term Debt xxxxxxxxxxxxxxx693 M
Total Debt xxxxxxxxxxxxxxx1,770 M
Goodwill - Gross xxxxxxxxxxxxxxx3,809 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1,611 M
Price To Book Value xxxxxxxxxxxxxxx2.85

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx383.4 M
Capex % of Sales xxxxxxxxxxxxxxx15.67 %
Cost of Goods Sold xxxxxxxxxxxxxxx727 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx1,394 M
Research & Development xxxxxxxxxxxxxxx407 M
Investments - Total xxxxxxxxxxxxxxx118 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

13/11/2026

1

Outperform

$161.80

103.91%

Macquarie explains Xero's 1H27 result supported the positive outlook, with revenue growth of 23% y/y (CC) boosted by accelerating Melio payments revenue and improving operating leverage.

Management now expects to achieve the Rule of 40 in FY27, 12 months ahead of schedule, with FY28 aspirations upgraded.

The analyst highlights AI is viewed as additive rather than disruptive, with 1m customers using AI features and engineering productivity improving 2.5 times.

Macquarie sees opportunities to monetise AI through bundled features, consumption-based pricing and customised solutions, supported by Xero's proprietary accounting data and established customer relationships.

Adjusted EPS forecasts rise 9%/2%/4% for FY27–FY29, due to higher payments revenue, lower Melio costs and the $1bn buyback.

Target price is raised to $161.80 from $158.50.

FORECAST
Macquarie forecasts a full year FY27 dividend of 0.00 cents and EPS of 130.46 cents.
Macquarie forecasts a full year FY28 dividend of 0.00 cents and EPS of 240.15 cents.

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

17/11/2026

1

Buy

$120.00

51.23%

Jarden retains a Buy rating for Xero with its target price increased to $120.00 from $117.00 following a 1H27 result underpinned by a US payments-led upgrade alongside steady growth across other core markets.

Jarden views the performance as further evidence of strategic progress, noting the US is becoming a larger growth contributor with improving product market fit and payments convergence validating the Melio acquisition.

Management now expects to reach the Rule of 40 in FY27, lifted its FY28 revenue aspiration above NZ$4.6bn excluding roughly US$70m in revenue synergies, and announced an on-market share buyback of up to NZ$1bn.

The lifted valuation reflects these forecast updates under a methodology equally weighted between 18x one-year forward EV/EBITDA and discounted cash flow.

XRO STOCK CHART